ERBB2 and breast cancer: Breast cancer (BC) is the most common cancer diagnosis (12% of total; 25% in women) and the leading cause of cancer death in women worldwide, with the majority of cases attributable to the hormone receptor-positive and HER2-negative (HR+/HER2-) subtype [1].